Produção Nacional
Revisado por pares
Krüppel-Like Factor 4
2008; Lippincott Williams & Wilkins; Volume: 102; Issue: 12 Linguagem: Norueguês
10.1161/circresaha.108.178954
ISSN1524-4571
Autores Tópico(s)Ferroptosis and cancer prognosis
ResumoHomeCirculation ResearchVol. 102, No. 12Krüppel-Like Factor 4 Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBKrüppel-Like Factor 4Transcriptional Regulator of Proliferation, or Inflammation, or Differentiation, or All Three? Michael V. Autieri Michael V. AutieriMichael V. Autieri From the Department of Physiology, Independence Blue Cross Cardiovascular Research Center, Temple University School of Medicine, Philadelphia Pa. Originally published20 Jun 2008https://doi.org/10.1161/CIRCRESAHA.108.178954Circulation Research. 2008;102:1455–1457The transcriptional response to vascular injury. The vascular response to injury is a dynamic and multifactorial process involving several cell types. As part of the vascular response to injury, normally quiescent, contractile vascular smooth muscle cells (VSMCs) respond to inflammatory and growth factors by transforming from a differentiated contractile state to a dedifferentiated synthetic phenotype capable of migration, proliferation, and synthesis of cytokines and extracellular matrix.1 As the major effector cell in this occlusive process, the VSMC must coordinate and synchronize immensely complex inflammatory, proliferative, and differentiation programs. Indeed, the activated "myofibroblastic" VSMCs can even express proteins and cytokines ascribed to be restricted to inflammatory cells.2,3 Several transcription factors have earned the moniker of "master switch" of inflammation (eg, NF-κB), or proliferation (eg, Egr-1), or differentiation (eg, myocardin).4–6 Is it possible, or even plausible, from a cellular standpoint, that a single transcription factor could potentially play an important part in all 3 of these processes?Krüppel ComplexityThe Krüppel-like family of transcription factors contain zinc finger DNA binding domains and presently include at least 16 mammalian members,7 with several having important roles in cardiovascular pathophysiology.8 One might think that there would be redundancy among so many family members; however, the non–zinc finger domain of these transcription factors displays structural heterogeneity, resulting in surprising functional diversity among Krüppel proteins.9 In particular, the role of Krüppel-like factor (KLF)4 in vascular biology and the mechanisms of its effects are as complex as the cells that participate in vascular disease are diverse.For example, in macrophages, KLF4 is induced by inflammatory stimuli and mediates induction of proinflammatory genes by 2 different, but complementary, mechanisms. In the first, KLF4 interacts with the NF-κB subunit p65 and cooperates with its transactivation of proinflammatory genes. In the other, KLF4 competes with Smad3, a mediator of transforming growth factor-β1 antiinflammatory signaling, for its coactivator, p300,10 resulting in inhibition of antiinflammatory gene expression. In endothelial cells (ECs), KLF4 is also induced by inflammatory stimuli and disturbances in laminar flow but with antiinflammatory effects. KLF4 exerts a protective, antiinflammatory phenotype in these cells also by binding to NF-κB subunits, but in ECs, this leads to an inhibition of NF-κB–mediated inflammatory gene expression.11 KLF4 also directly transactivates expression of antiinflammatory genes in ECs such as endothelial NO synthase.11KLF4 is not normally expressed in VSMCs in uninjured arteries but is transiently induced in rat carotid arteries by balloon angioplasty, where it functions in at least 2 ways.12 KLF4 participates in growth arrest of VSMCs by enhancement of p53 expression, and subsequent increase in 1 of its target genes p21WAF/Cip1, a potent suppressor of cell cycle progression.13 In VSMCs, KLF4 also drives phenotypic switching by suppression of smooth muscle cell (SMC) marker genes. KLF4 can bind the transforming growth factor-β control element in the promoter of SMC differentiation genes12,14,15 and also interact with serum response factor (SRF), preventing SRF from associating with promoters of SMC differentiation genes. KLF4 can also repress expression of the SRF coactivator myocardin. Clearly, KLF4 expression and activity has profound pleiotropic effects on multiple cell types that participate in vascular pathophysiology. Unfortunately, its effects in vivo have been understudied because of limited viability of KLF4 knockout (KO) mice.12KLF4 Regulates the Vascular Response to Injury by Multiple MechanismsIn this issue of Circulation Research, Yoshida et al16 circumvent lethality issues by using a tamoxifen-inducible KLF4 conditional deletion approach and clarify the role of this transcription factor in the in vivo VSMC response to injury. This work combines multiple in vivo and mechanistic approaches to address the function of KLF4 in regulation of intimal hyperplasia and is the first to report that abrogation of KLF4 enhanced development of neointima in ligation injured mice.In wild-type mice, KLF4 mRNA is rapidly and transiently expressed in response to ligation injury, which immediately preceded a decrease in the differentiation marker smooth muscle (SM)a actin mRNA expression. However, in KLF4 KO mice, this differentiation marker repression was delayed but not abrogated. Although not addressed by the authors, this suggests that other transcription regulators can compensate for KLF4; potential candidates for this other factor might be KLF5, because it can use the SM22α promoter in reporter assays,17 or KLF13 and/or KLF15, both expressed in SMCs and associated with the SM22α promoter.18,19One mechanism for the delay in repression of differentiation markers might be that chromatin immunoprecipitation analysis in lysates from ligated mouse carotid arteries determined that KLF4 bound to the transforming growth factor-β control element in the SMa actin and SM22α promoters. Medial cells in KLF4 KO mice demonstrated enhanced proliferation compared with control mice. This is surprising, and somewhat counterintuitive, considering the context of prolonged expression of differentiation markers in these KO mice.Prior studies indicated a strong relationship between KLF4 and expression of the p53 tumor suppressor.13 One target of p53 is p21WAF/Cip1, a potent negative regulator of cell cycle progression. Yoshida et al, provide multiple lines of mechanistic evidence to support the notion that a likely mechanism of KLF4 effects on growth regulation is that p21WAF/Cip1 expression is not increased by ligation injury in KLF4 KO mice, whereas forced KLF4 expression induced p21WAF/Cip1 protein expression in cultured VSMCs. Furthermore, KLF4 binding sites were identified in the p21WAF/Cip1 promoter, and KLF4 regulated p21WAF/Cip1 transactivation in a p53-dependent manner.Progression of intimal hyperplasia is initiated and sustained by the inflammatory response. One limitation to this study is that it cannot definitively be determined whether the inflammatory response was altered in these mice. The authors do report that inflammatory cell infiltration into the ligated artery was no different between KLF4 KO and wild-type mice, but nothing is known about the function of these KLF4-null inflammatory cells. KLF4 induces and regulates expression of inflammatory factors in macrophages,10 so one might expect reduced inflammation in injured arteries of these mice if they do not synthesize the appropriate repertoire of inflammatory factors. This would support the assertion by the authors that these proliferative effects are directly attributable to modulation of SMC gene transcription. On the other hand, we know ECs occupy a critical role in maintenance of the quiescent phenotype of VSMCs.1 In ECs, KLF4 expression is increased by shear stress, leading to increased expression of antiinflammatory factors, which would be expected in the ligated murine carotid arteries used in this study. It needs to be considered that lack of antiinflammatory signals from ECs could indirectly affect VSMC phenotype and contribute to increased neointima formation in vivo. As the authors appropriately point out in their discussion, cell-specific deletion of the klf4 gene is necessary to define the precise role of this protein in each of these cell types to fully characterize the role of this transcription factor in so dynamic a process development of intimal hyperplasia.PerspectiveOne can envision an in vivo scenario in which activated macrophages secrete inflammatory factors mediated by KLF4 expression, which induce ECs to assume an antiinflammatory, nonthrombogenic phenotype, also mediated by KLF4, which, in turn, stimulates KLF4 in SMCs, inducing an antiproliferative, yet dedifferentiated phenotype (Figure). In a larger sense, the seemingly paradoxical finding that differentiated SMCs can proliferate is perhaps the most important contribution by Yoshida et al and implicates KLF4 as a transcriptional link between proliferation and differentiation, at least in SMCs. However, it is not the end of the story, and, like most important studies, the report points out that additional studies necessary to determine the role of KLF4 in regulation of inflammatory gene expression in VSMCs. Like other zinc finger–containing proteins, the activity of the Krüppel proteins can be regulated not only by de novo synthesis but also by posttranslational modification and protein–protein interactions. How these are influenced by extracellular stimuli, both autocrine and paracrine, from other cell types remains to be elucidated.Identification and characterization of transcriptional regulators of intimal hyperplasia are not only crucial in our better understanding of this dynamic process but also represent potential targets for interventional modalities. KLF4 may indeed fit the bill as a single transcription factor that can play a central role in regulation of proliferation, or inflammation, or differentiation, and all 3.Download figureDownload PowerPointFigure. Cell type, outcome, and potential mechanisms of KLF4 pleiotropic effects on cells that participate in vascular pathophysiology. In macrophages, KLF4 interacts with p65 and cooperates with its transactivation of inflammatory genes. It also interacts with and inhibits Smad3 function, both leading inhibition of antiinflammatory gene expression. In ECs, KLF4 also interacts with p65 but exerts an antiinflammatory phenotype by inhibiting its activity. KLF4 also transactivates antithrombogenic genes. In SMCs, KLF4 cooperates with p53 to induce expression of the cell cycle inhibitor p21WAF/Cip1. KLF4 also inhibits SRF from binding to the transforming growth factor-β control element (TCE) in promoters of SMC genes and reduces expression of its coactivator, myocardin.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.Sources of FundingThe author is supported by the National Heart, Lung, and Blood Institute, American Heart Association, and Roche Organ Transplant Research Foundation.DisclosuresNone.FootnotesCorrespondence to Michael Autieri, PhD, Department of Physiology, Temple University School of Medicine, Room 810, MRB, 3420 N Broad St, Philadelphia PA 19140. E-mail [email protected] References 1 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362: 801–809.CrossrefMedlineGoogle Scholar2 Chen X, Kelemen SE, Autieri MV. Expression of granulocyte colony-stimulating factor is induced in injured rat carotid arteries and mediates vascular smooth muscle cell migration. Am J Physiol Cell Physiol. 2005; 288: C81–C88.CrossrefMedlineGoogle Scholar3 Autieri MV, Carbone C, Mu A. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arterioscler Thromb Vasc Biol. 2000; 20: 1737–1744.CrossrefMedlineGoogle Scholar4 De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000; 20: e83–e88.CrossrefMedlineGoogle Scholar5 Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res. 2006; 98: 186–191.LinkGoogle Scholar6 Parmacek MS. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res. 2007; 100: 633–644.LinkGoogle Scholar7 Atkins GB, Jain MK. Role of Krüppel-like transcription factors in endothelial biology. Circ Res. 2007; 100: 1686–1695.LinkGoogle Scholar8 Suzuki T, Aizawa K, Matsumura T, Nagai R. Vascular implications of the Krüppel-like family of transcription factors Arterioscler Thromb Vasc Biol. 2005; 25: 1135–1141.LinkGoogle Scholar9 Feinberg MW, Lin Z, Fisch S, Jain MK. An emerging role for Krüppel-like factors in vascular biology. Trends Cardiovasc Med. 2004; 14: 241–246.CrossrefMedlineGoogle Scholar10 Feinberg MW, Cao Z, Wara AK, Lebedeva MA, Senbanerjee S, Jain MK. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem. 2005; 280: 38247–38258.CrossrefMedlineGoogle Scholar11 Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, Katz J, Feinberg MW, Gerzsten RE, Edelman ER, Jain MK. Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem. 2007; 282: 13769–13779.CrossrefMedlineGoogle Scholar12 Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem. 2005; 280: 9719–9727.CrossrefMedlineGoogle Scholar13 Wassmann S, Wassmann K, Jung A, Velten M, Knuefermann P, Petoumenos V, Becher U, Werner C, Mueller C, Nickenig G. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J Mol Cell Cardiol. 2007; 43: 301–307.CrossrefMedlineGoogle Scholar14 Liu Y, Sinha S, Owens G. A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J Biol Chem. 2003; 278: 48004–48011.CrossrefMedlineGoogle Scholar15 Adam PJ, Regan CP, Hautmann MB, Owens GK. Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22αlpha in vivo. J Biol Chem. 2000; 275: 37798–37806.CrossrefMedlineGoogle Scholar16 Yoshida T, Kaestner KH, Owens GK. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res. 2008; 102: 1548–1557.LinkGoogle Scholar17 Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G, Shindo T, Maemura K, Kagechika H, Shudo K, Nagai R. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res. 2005; 97: 1132–1141.LinkGoogle Scholar18 Gray S, Feinberg MW, Hull S, Kuo CT, Watanabe M, Sen-Banerjee S, DePina A, Haspel R, Jain MK. The Krüppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J Biol Chem. 2002; 277: 34322–34328.CrossrefMedlineGoogle Scholar19 Martin KM, Ellis PD, Metcalfe JC, Kemp PR. Selective modulation of the SM22alpha promoter by the binding of BTEB3 (basal transcription element-binding protein 3) to TGGG repeats. Biochem J. 2003; 375: 457–463.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Zhang J, Xie M, Xia L, Yu T, He F, Zhao C, Qiu W, Zhao D, Liu Y, Gong Y, Yao C, Liu L and Wang Y (2018) Sublytic C5b-9 Induces IL-23 and IL-36a Production by Glomerular Mesangial Cells via PCAF-Mediated KLF4 Acetylation in Rat Thy-1 Nephritis, The Journal of Immunology, 10.4049/jimmunol.1800719, 201:11, (3184-3198), Online publication date: 1-Dec-2018. Roostalu U and Wong J (2018) Arterial smooth muscle dynamics in development and repair, Developmental Biology, 10.1016/j.ydbio.2018.01.018, 435:2, (109-121), Online publication date: 1-Mar-2018. Zhou B, Zeng S, Li N, Yu L, Yang G, Yang Y, Zhang X, Fang M, Xia J and Xu Y (2017) Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury, Arteriosclerosis, Thrombosis, and Vascular Biology, 37:4, (675-684), Online publication date: 1-Apr-2017. He M, Wang C, Sun J, Liu Y, Wang H, Zhao J, Li Y, Chang H, Hou J, Song J, Li A and Ji E (2017) Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3 activation induced by TNF-α in vascular smooth muscle cells, Biochemical Pharmacology, 10.1016/j.bcp.2017.04.018, 137, (51-60), Online publication date: 1-Aug-2017. Chen H, Yang H, Yue H, Strappe P, Xia P, Pan L, Zhang Y, Chai S, Chen S, Ma L and Wang L (2017) Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension, Heart, Lung and Circulation, 10.1016/j.hlc.2016.08.002, 26:5, (509-518), Online publication date: 1-May-2017. Lee S, Wottrich S and Bonavida B (2017) Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog), Tumor Biology, 10.1177/1010428317692253, 39:4, (101042831769225), Online publication date: 1-Apr-2017. Chettimada S, Joshi S, Dhagia V, Aiezza A, Lincoln T, Gupte R, Miano J and Gupte S (2016) Vascular smooth muscle cell contractile protein expression is increased through protein kinase G-dependent and -independent pathways by glucose-6-phosphate dehydrogenase inhibition and deficiency, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00335.2016, 311:4, (H904-H912), Online publication date: 1-Oct-2016. Lv H, Zhang Z, Wang Y, Li C, Gong W and Wang X MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 10.3727/096504016X14562725373833, 23:6, (283-290) Zitman-Gal T, Green J, Korzets Z, Bernheim J and Benchetrit S (2015) Kruppel-like factors in an endothelial and vascular smooth muscle cell coculture model: impact of a diabetic environment and vitamin D, In Vitro Cellular & Developmental Biology - Animal, 10.1007/s11626-014-9858-7, 51:5, (470-478), Online publication date: 1-May-2015. Liu Y, Sun X, Wu Y, Fang P, Shi H, Xu J and Li M (2015) Effects of miRNA-145 on airway smooth muscle cells function, Molecular and Cellular Biochemistry, 10.1007/s11010-015-2519-7, 409:1-2, (135-143), Online publication date: 1-Nov-2015. Mreich E, Chen X, Zaky A, Pollock C and Saad S (2015) The role of Krüppel-like factor 4 in transforming growth factor- β -induced inflammatory and fibrotic responses in human proximal tubule cells , Clinical and Experimental Pharmacology and Physiology, 10.1111/1440-1681.12405, 42:6, (680-686), Online publication date: 1-Jun-2015. Yang Z, Zheng B, Zhang Y, He M, Zhang X, Ma D, Zhang R, Wu X and Wen J (2015) miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 10.1016/j.bbadis.2015.04.012, 1852:7, (1477-1489), Online publication date: 1-Jul-2015. Junker J, Lönnqvist S, Rakar J, Karlsson L, Grenegård M and Kratz G (2013) Differentiation of human dermal fibroblasts towards endothelial cells, Differentiation, 10.1016/j.diff.2013.01.005, 85:3, (67-77), Online publication date: 1-Feb-2013. Zhang X, Zheng B, Gu C, Fu J and Wen J (2012) TGF-β1 Downregulates AT1 Receptor Expression via PKC-δ-Mediated Sp1 Dissociation From KLF4 and Smad-Mediated PPAR-γ Association With KLF4, Arteriosclerosis, Thrombosis, and Vascular Biology, 32:4, (1015-1023), Online publication date: 1-Apr-2012. Gocek E and Studzinski G (2011) Induction of Differentiation in Cancer Cells by Vitamin D: Recognition and Mechanisms Vitamin D and Cancer, 10.1007/978-1-4419-7188-3_7, (143-174), . Yu K, Zheng B, Han M and Wen J (2011) ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements, Cardiovascular Research, 10.1093/cvr/cvr017, 90:3, (464-474), Online publication date: 1-Jun-2011., Online publication date: 1-Jun-2011. Kuhn A, Schlauch K, Lao R, Halayko A, Gerthoffer W and Singer C (2010) MicroRNA Expression in Human Airway Smooth Muscle Cells, American Journal of Respiratory Cell and Molecular Biology, 10.1165/rcmb.2009-0123OC, 42:4, (506-513), Online publication date: 1-Apr-2010. Li H, Han M, Bernier M, Zheng B, Sun S, Su M, Zhang R, Fu J and Wen J (2010) Krüppel-like Factor 4 Promotes Differentiation by Transforming Growth Factor-β Receptor-mediated Smad and p38 MAPK Signaling in Vascular Smooth Muscle Cells, Journal of Biological Chemistry, 10.1074/jbc.M109.076992, 285:23, (17846-17856), Online publication date: 1-Jun-2010. Zheng B, Han M and Wen J (2010) Role of Krüppel-like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells, IUBMB Life, 10.1002/iub.298, (NA-NA), . Zheng B, Han M, Bernier M, Zhang X, Meng F, Miao S, He M, Zhao X and Wen J (2009) Krüppel-like Factor 4 Inhibits Proliferation by Platelet-derived Growth Factor Receptor β-mediated, Not by Retinoic Acid Receptor α-mediated, Phosphatidylinositol 3-Kinase and ERK Signaling in Vascular Smooth Muscle Cells, Journal of Biological Chemistry, 10.1074/jbc.M109.026989, 284:34, (22773-22785), Online publication date: 1-Aug-2009. Gocek E and Studzinski G (2009) Vitamin D and differentiation in cancer, Critical Reviews in Clinical Laboratory Sciences, 10.1080/10408360902982128, 46:4, (190-209), Online publication date: 1-Aug-2009. Moehle C and Owens G (2009) Krüppel-like Factors KLF2, KLF4, and KLF5: Central Regulators of Smooth Muscle Function The Biology of Krüppel-like Factors, 10.1007/978-4-431-87775-2_15, (185-204), . Ke B, Zhang A, Wu X and Fang X (2015) The Role of Krüppel-like Factor 4 in Renal Fibrosis, Frontiers in Physiology, 10.3389/fphys.2015.00327, 6 June 20, 2008Vol 102, Issue 12 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCRESAHA.108.178954PMID: 18566311 Originally publishedJune 20, 2008 Keywordsproliferationtranscription factorKrüppel-like factor 4phenotypic switchPDF download Advertisement
Referência(s)